Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New eczema cream shows promise for kids ages 2-5

NCT ID NCT04845620

Symptom relief Sponsor: Arcutis Biotherapeutics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a cream called ARQ-151 on 652 children aged 2 to 5 with eczema (atopic dermatitis). The cream was applied once daily for 4 weeks. The goal was to see if it could clear or nearly clear the skin rash better than a cream with no active ingredient. The study is complete and focused on safety and how well the cream works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

652 people

The number who actually took part.

Started

Apr 2021

Finished

Jun 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 5 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Informed consent by parent(s) or legal guardian as required by local laws. 2. Males and females, ages 2 to 5 years old at time of signing Informed Consent (Screening) and at Baseline (Day 1). 3. Diagnosed with atopic dermatitis for at least 6 weeks, as determined by the Investigator. Stable disease for the past 4 weeks with no significant flares in atopic dermatitis before screening. 4. In good health as judged by the Investigator. 5. Subjects considered reliable and capable of adhering to the Protocol and visit schedule, according to the judgment of the Investigator. Exclusion Criteria: 1. Subjects with any serious medical condition or clinically significant abnormality that would prevent study participation or place the subject at significant risk, as judged by the Investigator 2. Has unstable AD or any consistent requirement for high potency topical steroids. 3. Subjects who are unwilling to refrain from prolonged sun exposure for 4 weeks prior to Baseline/Day 1 and during the study. 4. Previous treatment with ARQ-151. 5. Parent(s)/legal guardian(s) who are unable to communicate, read, or understand the local language(s). Subjects who are unable to communicate, read or understand the local language, or who display another condition, which in the Investigator's opinion, makes them unsuitable for clinical study participation. 6. Subjects who are family members of the clinical study site, clinical study staff, or sponsor, or family members of enrolled (in other studies of ARQ-151) subjects living in the same house.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis (eczema) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atopic dermatitis (eczema)

Contacts and locations

Locations

  • Arcutis Clinical Site 01

    Gresham, Oregon, 97030, United States

  • Arcutis Clinical Site 02

    San Antonio, Texas, 78213, United States

  • Arcutis Clinical Site 03

    South Jordan, Utah, 84095, United States

  • Arcutis Clinical Site 04

    Houston, Texas, 77030, United States

  • Arcutis Clinical Site 05

    New Brighton, Minnesota, 55112, United States

  • Arcutis Clinical Site 06

    Burke, Virginia, 22015, United States

  • Arcutis Clinical Site 07

    Rolling Meadows, Illinois, 33770, United States

  • Arcutis Clinical Site 08

    Austin, Texas, 78759, United States

  • Arcutis Clinical Site 09

    Inglewood, California, 90301, United States

  • Arcutis Clinical Site 10

    Miami Lakes, Florida, 33014, United States

  • Arcutis Clinical Site 11

    Delray Beach, Florida, 33484, United States

  • Arcutis Clinical Site 12

    Coral Gables, Florida, 33146, United States

  • Arcutis Clinical Site 13

    Rockville, Maryland, 20850, United States

  • Arcutis Clinical Site 14

    Birmingham, Alabama, 35244, United States

  • Arcutis Clinical Site 15

    Rockville, Maryland, 20850, United States

  • Arcutis Clinical Site 16

    Reno, Nevada, 89509, United States

  • Arcutis Clinical Site 18

    San Antonio, Texas, 78218, United States

  • Arcutis Clinical Site 20

    Sandy Springs, Georgia, 30328, United States

  • Arcutis Clinical Site 21

    Plainfield, Indiana, 46168, United States

  • Arcutis Clinical Site 22

    Louisville, Kentucky, 40217, United States

  • Arcutis Clinical Site 24

    Newtown Square, Pennsylvania, 19073, United States

  • Arcutis Clinical Site 25

    Spokane, Washington, 99202, United States

  • Arcutis Clinical Site 26

    Scottsdale, Arizona, 85255, United States

  • Arcutis Clinical Site 27

    Bellaire, Texas, 77401, United States

  • Arcutis Clinical Site 28

    Largo, Florida, 33770, United States

  • Arcutis Clinical Site 29

    Calgary, Alberta, T2J 7E1, Canada

  • Arcutis Clinical Site 30

    San Diego, California, 92123, United States

  • Arcutis Clinical Site 31

    Hershey, Pennsylvania, 17033, United States

  • Arcutis Clinical Site 32

    Rochester, New York, 14623, United States

  • Arcutis Clinical Site 33

    Coral Gables, Florida, 33134, United States

  • Arcutis Clinical Site 34

    Lake Charles, Louisiana, 70605, United States

  • Arcutis Clinical Site 35

    North Miami Beach, Florida, 33162, United States

  • Arcutis Clinical Site 36

    Clarkston, Michigan, 48346, United States

  • Arcutis Clinical Site 36

    Markham, Ontario, L3P 1X3, Canada

  • Arcutis Clinical Site 39

    Summerville, South Carolina, 29486, United States

  • Arcutis Clinical Site 40

    Metairie, Louisiana, 70006, United States

  • Arcutis Clinical Site 41

    Bay City, Michigan, 48706, United States

  • Arcutis Clinical Site 42

    Clarksville, Indiana, 47129, United States

  • Arcutis Clinical Site 43

    Miami, Florida, 33173, United States

  • Arcutis Clinical Site 44

    New York, New York, 11415, United States

  • Arcutis Clinical Site 45

    Rancho Santa Margarita, California, 92688, United States

  • Arcutis Clinical Site 46

    Louisville, Kentucky, 40241, United States

  • Arcutis Clinical Site 47

    Saint Joseph, Missouri, 64506, United States

  • Arcutis Clinical Site 48

    Boca Raton, Florida, 33486, United States

  • Arcutis Clinical Site 50

    Bryant, Arkansas, 72022, United States

  • Arcutis Clinical Site 51

    Metairie, Louisiana, 70005, United States

  • Arcutis Clinical Site 52

    Portland, Oregon, 97210, United States

  • Arcutis Clinical Site 53

    Auburn Hills, Michigan, 48326, United States

  • Arcutis Clinical Site 54

    Brooklyn, New York, 11203, United States

  • Arcutis Clinical Site 55

    Lebanon, New Hampshire, 03756, United States

  • Arcutis Clinical Site 56

    Birmingham, Alabama, 35209, United States

  • Arcutis Clinical Site 57

    West Lafayette, Indiana, 47906, United States

  • Arcutis Clinical Site 58

    Cincinnati, Ohio, 45229, United States

  • Arcutis Clinical Site 59

    Fort Smith, Arkansas, 72916, United States

  • Arcutis Clinical Site 60

    Chicago, Illinois, 60607, United States

  • Arcutis Clinical Site 61

    Grapevine, Texas, 76051, United States

  • Arcutis Clinical Site 62

    Charleston, South Carolina, 29425, United States

  • Arcutis Clinical Site 63

    Portland, Oregon, 97239, United States

  • Arcutis Clinical Site 64

    Winnipeg, Manitoba, R3C 0N2, Canada

  • Arcutis Clinical Site 65

    Bethlehem, Pennsylvania, 18105, United States

  • Arcutis Clinical Site 66

    Frisco, Texas, 75034, United States

  • Arcutis Clinical Site 68

    Gilbert, Arizona, 85234, United States

  • Arcutis Clinical Site 69

    Montgomery, Alabama, 36117, United States

  • Arcutis Clinical Site 70

    Thousand Oaks, California, 91320, United States

  • Arcutis Clinical Site 71

    Little Rock, Arkansas, 72212, United States

  • Arcutis Clinical Site 72

    Troy, Michigan, 48084, United States

  • Arcutis Clinical Site 73

    Burlington, Ontario, L7L 6W6, Canada

  • Arcutis Clinical Site 74

    Fort Worth, Texas, 76244, United States

  • Arcutis Clinical Site 75

    Wellington, Florida, 33449, United States

  • Arcutis Clinical Site 76

    Charlottesville, Virginia, 22902, United States

  • Arcutis Clinical Site 77

    Columbia, Maryland, 21045, United States

  • Arcutis Clinical Site 78

    Saskatoon, Saskatchewan, S7K 2C1, Canada

  • Arcutis Clinical Site 79

    Miami, Florida, 33137, United States

  • Arcutis Clinical Site 81

    Mason, Ohio, 45040, United States

  • Arcutis Clinical Site 82

    Boise, Idaho, 83706, United States

  • Arcutis Clinical Site 84

    Baton Rouge, Louisiana, 70808, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.